• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自1999年美国神经病学学会(AAN)肌萎缩侧索硬化症(ALS)实践参数发布以来,ALS管理方面的变化。

Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999.

作者信息

Bradley W G, Anderson F, Gowda N, Miller R G

机构信息

University of Miami School of Medicine, Department of Neurology, Miami, FL 33101, USA.

出版信息

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):240-4.

PMID:15799554
Abstract

OBJECTIVE

To determine if the publication in 1999 of the AAN Practice Parameter on ALS was associated with an improvement in the standard of management of the disease.

METHODS

Data on 646 patients enrolled in the ALS CARE database and on 465 patients who died in the period May 2001 to November 2002 were compared with similar data obtained from the database from 1996 to May 1999.

RESULTS

The specialty ALS clinics were the most important source of information about ALS. The internet was a source for 39%. The treatment of sialorrhea, pseudobulbar emotional lability, and failure of swallowing and breathing had all improved significantly in the period after the publication of the Practice Parameter. However many patients still did not receive a gastrostomy tube or non-invasive positive pressure ventilation when indicated by the Practice Parameter, mainly because of lack of patient compliance. Cost was the main reason why 41% of patients did not receive riluzole, though they spent a third of the cost of this medication on alternative medicines.

CONCLUSIONS

The publication of the AAN Practice Parameter was associated with improvement in the standard of care. Most cases in the database come from specialized ALS centers, and further information on the community care of ALS patients is needed.

摘要

目的

确定美国神经病学学会(AAN)1999年发布的肌萎缩侧索硬化症(ALS)实践参数是否与该疾病管理标准的改善相关。

方法

将ALS护理数据库中登记的646例患者以及2001年5月至2002年11月期间死亡的465例患者的数据,与1996年至1999年5月从该数据库获得的类似数据进行比较。

结果

ALS专科诊所是关于ALS最重要的信息来源。互联网是39%的信息来源。在实践参数发布后的这段时间里,流涎、假性延髓情绪不稳定以及吞咽和呼吸功能衰竭的治疗均有显著改善。然而,许多患者在实践参数表明需要时仍未接受胃造瘘管或无创正压通气,主要原因是患者依从性差。费用是41%的患者未接受利鲁唑治疗的主要原因,尽管他们在替代药物上花费了这种药物三分之一的费用。

结论

AAN实践参数的发布与护理标准的改善相关。数据库中的大多数病例来自ALS专科中心,需要进一步了解ALS患者的社区护理情况。

相似文献

1
Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999.自1999年美国神经病学学会(AAN)肌萎缩侧索硬化症(ALS)实践参数发布以来,ALS管理方面的变化。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):240-4.
2
Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.肌萎缩侧索硬化症的疗效研究:从肌萎缩侧索硬化症临床评估、研究与教育数据库中汲取的经验教训。
Ann Neurol. 2009 Jan;65 Suppl 1:S24-8. doi: 10.1002/ana.21556.
3
Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology.肌萎缩侧索硬化症的当前管理:肌萎缩侧索硬化症护理数据库与美国神经病学学会实践参数的比较。美国神经病学学会。
Neurology. 2001 Aug 14;57(3):500-4. doi: 10.1212/wnl.57.3.500.
4
[Management and care for patients with ALS].[肌萎缩侧索硬化症患者的管理与护理]
Rinsho Shinkeigaku. 2006 Nov;46(11):828-31.
5
The ALS Patient Care Database: insights into end-of-life care in ALS.肌萎缩侧索硬化症患者护理数据库:对肌萎缩侧索硬化症临终护理的见解。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8. doi: 10.1080/14660820152882214.
6
Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters.遵循美国神经病学学会(AAN)肌萎缩侧索硬化症(ALS)实践参数的多学科ALS中心护理成本的前瞻性研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):119-27. doi: 10.3109/21678421.2015.1091478. Epub 2015 Oct 13.
7
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology.神经病学质量改进:肌萎缩侧索硬化症质量衡量标准:美国神经病学学会质量衡量和报告小组委员会的报告。
Neurology. 2013 Dec 10;81(24):2136-40. doi: 10.1212/01.wnl.0000437305.37850.f9. Epub 2013 Nov 22.
8
Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis.无创通气在肌萎缩侧索硬化症患者中的应用。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Mar;5(1):9-15. doi: 10.1080/14660820310017335.
9
Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.肌萎缩侧索硬化症管理的良好实践:临床指南。基于证据的综述及良好实践要点。EALSC工作组。
Amyotroph Lateral Scler. 2007 Aug;8(4):195-213. doi: 10.1080/17482960701262376.
10
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers.意大利肌萎缩侧索硬化症护理:一项在神经科中心开展的全国性研究。
J Neurol Sci. 2001 Oct 15;191(1-2):145-50. doi: 10.1016/s0022-510x(01)00622-0.

引用本文的文献

1
Placebo-Controlled, Randomized Double-Blind N-Of-1 Trial to Study Safety and Potential Efficacy of TJ-68 for Improving Muscle Cramps in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study.安慰剂对照、随机双盲N-of-1试验,以研究TJ-68改善肌萎缩侧索硬化症患者肌肉痉挛的安全性和潜在疗效:一项初步研究。
Muscle Nerve. 2025 Sep;72(3):485-492. doi: 10.1002/mus.28459. Epub 2025 Jun 23.
2
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.肠内管饲用于肌萎缩侧索硬化/运动神经元病。
Cochrane Database Syst Rev. 2023 Aug 10;8(8):CD004030. doi: 10.1002/14651858.CD004030.pub4.
3
Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial.
随机双盲个体化 N-of-1 临床试验,以测试 TJ-68 治疗肌萎缩侧索硬化症(ALS)肌肉痉挛的安全性和潜在疗效:TJ-68 试验研究方案。
Trials. 2023 Jul 10;24(1):449. doi: 10.1186/s13063-023-07424-8.
4
Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.使用患者报告的呼吸困难症状对运动神经元病患者的呼吸功能进行筛查。
J Neurol. 2020 Nov;267(11):3310-3318. doi: 10.1007/s00415-020-10003-5. Epub 2020 Jun 23.
5
Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions.探索肌萎缩侧索硬化症的靶点和疗法:饮食干预的当前见解
Degener Neurol Neuromuscul Dis. 2017 Jul 25;7:95-108. doi: 10.2147/DNND.S120607. eCollection 2017.
6
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的补充和替代疗法
Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8.
7
Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives.肌萎缩侧索硬化症患者对接受或拒绝无创通气或胃造口术的看法。
J Neurol. 2015;262(4):1002-13. doi: 10.1007/s00415-015-7665-z. Epub 2015 Feb 17.
8
Respiratory and nutritional support in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的呼吸和营养支持。
Curr Treat Options Neurol. 2014 Feb;16(2):270. doi: 10.1007/s11940-013-0270-5.
9
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology.神经病学质量改进:肌萎缩侧索硬化症质量衡量标准:美国神经病学学会质量衡量和报告小组委员会的报告。
Neurology. 2013 Dec 10;81(24):2136-40. doi: 10.1212/01.wnl.0000437305.37850.f9. Epub 2013 Nov 22.
10
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的肠内管饲喂养
Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD004030. doi: 10.1002/14651858.CD004030.pub3.